Galectin-3 expression is prognostic in diffuse type gastric adenocarcinoma, confers aggressive phenotype, and can be targeted by YAP1/BET inhibitors.
British journal of cancer | 2018-01-01 | PMID 29136404
Ajani Jaffer A, Estrella Jeannelyn S, Chen Qiongrong and 20 more
Genes: YAP1, MYC
